What the data shows
The STEP-4 trial randomized weight-loss responders to either continue semaglutide or switch to placebo. After 48 weeks:
- Continuation group: continued losing or maintained weight
- Discontinuation group: regained ~6.9% body weight (roughly 2/3 of what was lost)
- Metabolic markers (lipids, blood pressure, HbA1c) reverted in the discontinuation group
Timeline after stopping
| Time post-stop | Typical changes |
|---|---|
| Week 1-2 | Drug clearing; minimal change |
| Week 3-4 | Appetite returns; food noise rises |
| Month 2-3 | 2-4 lb regain typical |
| Month 6 | Half the lost weight often regained |
| Month 12 | Most patients at 60-70% of pre-treatment weight |
Why regain happens
Three drivers:
- Appetite returns. The drug suppressed it; that suppression ends.
- Body composition didn't change enough. If muscle was lost during the cut, RMR is now lower than pre-treatment, making maintenance harder.
- Behaviors didn't fully reset. If you didn't build sustainable lifestyle habits during the loss, the old habits come back with the appetite.
Maintenance options
| Option | What it looks like |
|---|---|
| Continue at maintenance dose | Stay on a moderate dose indefinitely. Most reliable for keeping the weight off. |
| Microdose maintenance | Drop to 0.25-0.5 mg semaglutide weekly (or equivalent tirzepatide). Often enough to keep appetite in check. See. |
| Strategic re-treatment | Stop, monitor, restart if 5+ lb regain occurs. |
| Full discontinuation + lifestyle | Possible for those with strong protein/training/sleep foundation. Hardest path; works for some. |
Tapering approach
If choosing to stop, taper rather than abruptly discontinue:
- Reduce dose by 25-50% for 4-8 weeks
- Continue intensive lifestyle work (training, protein, sleep)
- Monitor weight weekly
- Reassess at month 3, restart, microdose, or continue tapering
The reality: Obesity behaves like a chronic condition. Stopping treatment without a maintenance protocol is like stopping a blood pressure medication and expecting blood pressure to stay low. For some it does; for most it doesn't.
Bottom line
Stopping semaglutide without a maintenance plan typically results in significant regain within 12 months. The fix is choosing the right ongoing protocol: continued therapy, microdose maintenance, or rigorous lifestyle work with proactive monitoring. The right choice depends on goals, risk tolerance, and what you can sustain. Discuss with the prescribing physician, abrupt discontinuation without a plan is rarely the best path.